Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma

Autor: Esteve-Codina, A, Alameda, F, Carrato, C, Pineda, E, Arpi, O, Martinez-Garcia, M, Mallo, M, Gut, M, Dabad, M, Tortosa, A, Del Barco, S, Capellades, J, Puig, J, Gallego, O, Pujol, T, Oleaga, L, Gil-Gil, M, de Quintana-Schmidt, C, Valduvieco, I, Martinez-Cardus, A, Bellosillo, B, Munoz-Marmol, AM, Esteve, A, Domenech, M, Camins, A, Craven-Bartle, J, Villa, S, Marruecos, J, Domenech, S, de la Iglesia, N, Balana, C, Bagué S., Aldecoa, Iban

Publikováno v: CLINICAL CANCER RESEARCH
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Purpose: Glioblastoma is the most aggressive brain tumor in adults and has few therapeutic options. The study of molecular subtype classifications may lead to improved prognostic classification and identification of new therapeutic targets. The Cance

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::4839c4d75cc3573172258b7559e0a5da
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5102

Autocrine CCL5 effect mediates trastuzumab resistance by ERK pathway activation in HER2-positive breast cancer

Autor: Zazo S, Gonzalez-Alonso P, Martin-Aparicio E, Chamizo C, Luque M, Sanz-Alvarez M, Minguez P, Gomez-Lopez G, Cristobal I, Carames C, Garcia-Foncillas J, Eroles P, Lluch A, Arpi O, Rovira A, Albanell J, Madoz-Gurpide J, Rojo F

Publikováno v: MOLECULAR CANCER THERAPEUTICS
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

HER2-positive breast cancer is currently managed with chemotherapy in combination with specific anti-HER2 therapies, including trastuzumab. However, a high percentage of patients with HER2-positive tumors do not respond to trastuzumab (primary resist

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::d3a0ae64ea01e1c92d9da343bed95c2d
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=4444

Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-small ka, CyrillicB target genes in human breast cancer

Autor: Dalmases, A., Gonzalez, I., Menendez, S., Arpi, O., Corominas, J., Servitja, S., Tusquets, I., Chamizo, C., Rincon, R., Espinosa, L., Bigas, A., Eroles, P., Furriol, J., Lluch, A., Rovira, A., Albanell, J., Rojo, F.

Publikováno v: Oncotarget, 5, 1, pp. 196-210
Oncotarget, 5, 196-210

Item does not contain fulltext NF-small ka, CyrillicB has been linked to doxorubicin resistance in breast cancer patients. NF-small ka, CyrillicB nuclear translocation and DNA binding in doxorubicin treated-breast cancer cells have been extensively e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::141ac83cc701c879e0a5dc2d87870c97
https://hdl.handle.net/2066/137746

111P Adenosine pathway and exhaustion markers in peripheral T-cell correlate with benefit from immunotherapy in advanced non-small cell lung cancer

Autor: Moliner, L., Galindo-Campos, M.A., Hardy-Werbin, M., Del Rey-Vergara, R., Arpí, O., Villanueva, X., Gonzalez, S., Taus, Á., Rocha, P., Arriola, E.

Publikováno v: In Annals of Oncology September 2020 31 Supplement 4:S285-S285